Marilyn Kwan to Drug Monitoring
This is a "connection" page, showing publications Marilyn Kwan has written about Drug Monitoring.
Connection Strength
0.971
-
Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer. JNCI Cancer Spectr. 2026 Nov 02; 10(6).
Score: 0.971